1. Home
  2. NTLA vs WEST Comparison

NTLA vs WEST Comparison

Compare NTLA & WEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • WEST
  • Stock Information
  • Founded
  • NTLA 2014
  • WEST 2009
  • Country
  • NTLA United States
  • WEST United States
  • Employees
  • NTLA N/A
  • WEST N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WEST Beverages (Production/Distribution)
  • Sector
  • NTLA Health Care
  • WEST Consumer Staples
  • Exchange
  • NTLA Nasdaq
  • WEST Nasdaq
  • Market Cap
  • NTLA 794.5M
  • WEST 640.7M
  • IPO Year
  • NTLA 2016
  • WEST N/A
  • Fundamental
  • Price
  • NTLA $10.68
  • WEST $6.41
  • Analyst Decision
  • NTLA Buy
  • WEST Strong Buy
  • Analyst Count
  • NTLA 19
  • WEST 5
  • Target Price
  • NTLA $35.11
  • WEST $10.60
  • AVG Volume (30 Days)
  • NTLA 4.9M
  • WEST 290.6K
  • Earning Date
  • NTLA 08-07-2025
  • WEST 08-07-2025
  • Dividend Yield
  • NTLA N/A
  • WEST N/A
  • EPS Growth
  • NTLA N/A
  • WEST N/A
  • EPS
  • NTLA N/A
  • WEST N/A
  • Revenue
  • NTLA $45,569,000.00
  • WEST $872,022,000.00
  • Revenue This Year
  • NTLA N/A
  • WEST $22.72
  • Revenue Next Year
  • NTLA N/A
  • WEST $14.75
  • P/E Ratio
  • NTLA N/A
  • WEST N/A
  • Revenue Growth
  • NTLA N/A
  • WEST 2.38
  • 52 Week Low
  • NTLA $5.90
  • WEST $5.28
  • 52 Week High
  • NTLA $28.18
  • WEST $10.19
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 69.70
  • WEST 48.33
  • Support Level
  • NTLA $8.98
  • WEST $5.65
  • Resistance Level
  • NTLA $11.08
  • WEST $6.02
  • Average True Range (ATR)
  • NTLA 0.69
  • WEST 0.30
  • MACD
  • NTLA 0.16
  • WEST -0.00
  • Stochastic Oscillator
  • NTLA 88.96
  • WEST 48.22

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About WEST Westrock Coffee Company

Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.

Share on Social Networks: